Viridian Therapeutics
VRDN
VRDN
132 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 16 closing their positions.
Holders
132
Holders Change
+9
Holders Change %
+7.32%
% of All Funds
1.94%
Holding in Top 10
10
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+900%
% of All Funds
0.15%
New
25
Increased
49
Reduced
43
Closed
16
Calls
$1.85M
Puts
$590K
Net Calls
+$1.26M
Net Calls Change
+$2.3M
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$166M |
2 |
MC
2
Maverick Capital
Dallas,
Texas
|
$50.7M |
3 |
PBA
3
Paradigm Biocapital Advisors
New York
|
$104M |
4 |
VPC
4
Vestal Point Capital
New York
|
$21.8M |
5 |
VA
5
VR Adviser
New York
|
$84.6M |